1. Home
  2. KALV vs SSTK Comparison

KALV vs SSTK Comparison

Compare KALV & SSTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALV
  • SSTK
  • Stock Information
  • Founded
  • KALV N/A
  • SSTK 2003
  • Country
  • KALV United States
  • SSTK United States
  • Employees
  • KALV N/A
  • SSTK N/A
  • Industry
  • KALV Biotechnology: Pharmaceutical Preparations
  • SSTK EDP Services
  • Sector
  • KALV Health Care
  • SSTK Technology
  • Exchange
  • KALV Nasdaq
  • SSTK Nasdaq
  • Market Cap
  • KALV 642.3M
  • SSTK 668.4M
  • IPO Year
  • KALV N/A
  • SSTK 2012
  • Fundamental
  • Price
  • KALV $14.31
  • SSTK $19.29
  • Analyst Decision
  • KALV Strong Buy
  • SSTK Buy
  • Analyst Count
  • KALV 9
  • SSTK 4
  • Target Price
  • KALV $26.29
  • SSTK $43.67
  • AVG Volume (30 Days)
  • KALV 2.0M
  • SSTK 266.0K
  • Earning Date
  • KALV 07-10-2025
  • SSTK 08-05-2025
  • Dividend Yield
  • KALV N/A
  • SSTK 6.88%
  • EPS Growth
  • KALV N/A
  • SSTK N/A
  • EPS
  • KALV N/A
  • SSTK 1.09
  • Revenue
  • KALV N/A
  • SSTK $963,567,000.00
  • Revenue This Year
  • KALV N/A
  • SSTK $11.31
  • Revenue Next Year
  • KALV $347.19
  • SSTK $2.40
  • P/E Ratio
  • KALV N/A
  • SSTK $17.68
  • Revenue Growth
  • KALV N/A
  • SSTK 10.30
  • 52 Week Low
  • KALV $7.30
  • SSTK $14.35
  • 52 Week High
  • KALV $16.32
  • SSTK $46.10
  • Technical
  • Relative Strength Index (RSI)
  • KALV 58.58
  • SSTK 53.37
  • Support Level
  • KALV $11.10
  • SSTK $19.37
  • Resistance Level
  • KALV $16.32
  • SSTK $20.38
  • Average True Range (ATR)
  • KALV 1.10
  • SSTK 0.68
  • MACD
  • KALV 0.36
  • SSTK 0.05
  • Stochastic Oscillator
  • KALV 68.95
  • SSTK 53.97

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

Share on Social Networks: